163 related articles for article (PubMed ID: 9263645)
21. Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.
Frawley R; White K; Brown R; Musgrove D; Walker N; Germolec D
Environ Health Perspect; 2011 Mar; 119(3):371-6. PubMed ID: 21041162
[TBL] [Abstract][Full Text] [Related]
22. Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance.
Ishimaru N; Takagi A; Kohashi M; Yamada A; Arakaki R; Kanno J; Hayashi Y
J Immunol; 2009 May; 182(10):6576-86. PubMed ID: 19414813
[TBL] [Abstract][Full Text] [Related]
23. Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation.
Kremer J; Gleichmann E; Esser C
J Immunol; 1994 Sep; 153(6):2778-86. PubMed ID: 8077682
[TBL] [Abstract][Full Text] [Related]
24. Alterations of dendritic cells in the rat thymus without epithelial cell loss during cyclosporine treatment and recovery.
De Waal EJ; Rademakers LH; Schuurman HJ; Vos JG; Van Loveren H
Toxicology; 1996 Jun; 110(1-3):133-51. PubMed ID: 8658554
[TBL] [Abstract][Full Text] [Related]
25. The intrathymic target cell for the thymotoxic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
De Heer C; De Waal EJ; Schuurman HJ; Vos JG; Van Loveren H
Exp Clin Immunogenet; 1994; 11(2-3):86-93. PubMed ID: 7826669
[TBL] [Abstract][Full Text] [Related]
26. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fine JS; Silverstone AE; Gasiewicz TA
J Immunol; 1990 Feb; 144(4):1169-76. PubMed ID: 2303704
[TBL] [Abstract][Full Text] [Related]
27. Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1
Sawanobori Y; Kitazawa Y; Ueta H; Matsuno K; Tokuda N
Histochem Cell Biol; 2021 Aug; 156(2):133-146. PubMed ID: 33993340
[TBL] [Abstract][Full Text] [Related]
28. Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity.
Schuurman HJ; Van Loveren H; Rozing J; Vos JG
Int J Immunopharmacol; 1992 Apr; 14(3):369-75. PubMed ID: 1618591
[TBL] [Abstract][Full Text] [Related]
29. Thymocyte apoptosis as a mechanism for tributyltin-induced thymic atrophy in vivo.
Raffray M; Cohen GM
Arch Toxicol; 1993; 67(4):231-6. PubMed ID: 8517778
[TBL] [Abstract][Full Text] [Related]
30. T cell-derived IL-5 production is a sensitive target of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Inouye K; Pan X; Imai N; Ito T; Takei T; Tohyama C; Nohara K
Chemosphere; 2005 Aug; 60(7):907-13. PubMed ID: 15992597
[TBL] [Abstract][Full Text] [Related]
31. The thymus does not mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin-elicited alterations in bone marrow lymphocyte stem cells.
Frazier DE; Silverstone AE; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Feb; 124(2):242-7. PubMed ID: 8122269
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis as a mechanism of tributyltin cytotoxicity to thymocytes: relationship of apoptotic markers to biochemical and cellular effects.
Raffray M; McCarthy D; Snowden RT; Cohen GM
Toxicol Appl Pharmacol; 1993 Mar; 119(1):122-30. PubMed ID: 8470116
[TBL] [Abstract][Full Text] [Related]
33. Prothymocyte activity is reduced by perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Fine JS; Gasiewicz TA; Fiore NC; Silverstone AE
J Pharmacol Exp Ther; 1990 Oct; 255(1):128-32. PubMed ID: 2213547
[TBL] [Abstract][Full Text] [Related]
34. Immunotoxicity of bis(tri-n-butyltin) oxide in the rat.
Verdier F; Virat M; Schweinfurth H; Descotes J
J Toxicol Environ Health; 1991 Mar; 32(3):307-17. PubMed ID: 1900536
[TBL] [Abstract][Full Text] [Related]
35. Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis.
Kamath AB; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1998 May; 150(1):117-24. PubMed ID: 9630460
[TBL] [Abstract][Full Text] [Related]
36. In vitro exposure effects of cyclosporin A and bis(tri-n-butyltin)oxide on lymphocyte proliferation, cytokine (receptor) mRNA expression, and cell surface marker expression in rat thymocytes and splenocytes.
Vandebriel RJ; Spiekstra SW; Hudspith BN; Meredith C; Van Loveren H
Toxicology; 1999 Jul; 135(1):49-66. PubMed ID: 10454224
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8-tetrachlorodibenzo-p-dioxin.
Staples JE; Fiore NC; Frazier DE; Gasiewicz TA; Silverstone AE
Toxicol Appl Pharmacol; 1998 Jul; 151(1):200-10. PubMed ID: 9705904
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine-induced cell-mediated injury of the thymic medullary epithelium.
Beschorner WE; Olson JL; Hess AD; Di Gennaro KA; Santos GW
Transplantation; 1988 Apr; 45(4):797-803. PubMed ID: 3282361
[TBL] [Abstract][Full Text] [Related]
39. Bis(tri-n-butyltin)oxide induces programmed cell death (apoptosis) in immature rat thymocytes.
Raffray M; Cohen GM
Arch Toxicol; 1991; 65(2):135-9. PubMed ID: 2059153
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo.
Kamath AB; Xu H; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1997 Feb; 142(2):367-77. PubMed ID: 9070360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
